Comparative Analysis of U-Net and U-Net3 + for Retinal Exudate Segmentation: Performance Evaluation Across Regions.

J Imaging Inform Med

Department of Biomedical Engineering, College of IT Convergence, Gachon University, Seongnam, Korea.

Published: February 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Diabetic retinopathy is a major complication of diabetes, with its prevalence nearly doubling to approximately 10.5% by 2021. Exudates, the characteristic lesions of diabetic retinopathy, are crucial for assessing disease progression and severity. The location and distribution of these exudates can affect various regions of the retina, necessitating a detailed regional analysis of lesions. To address this need, this study aimed to evaluate the performance of exudate detection in fundus images across various regions, including perivascular and extravascular areas, perifoveal and extrafoveal regions, and in quadrants defined relative to the fovea. We employed U-net and U-net3 + deep learning models for validation, evaluating their performance using accuracy, sensitivity, specificity, and Dice score. Overall, the U-net3 + model outperformed the U-net model. Therefore, the performance evaluation was based on the results from the U-net3 + model. Comparing the detection performance across perivascular versus extravascular and perifoveal versus extrafoveal regions, the U-net3 + model achieved highest Dice score in the extravascular (87.96% [± 5.80]) and perifoveal areas (88.03% [± 5.86]). Additionally, superior sensitivity and Dice scores were observed in the top-left and top-right quadrants. Future research is anticipated to show that deep learning-based automatic exudate detection will enhance diagnostic accuracy and efficiency, leading to better treatment and prognosis in patients with diabetic retinopathy.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10278-025-01419-4DOI Listing

Publication Analysis

Top Keywords

diabetic retinopathy
12
performance evaluation
8
exudate detection
8
extrafoveal regions
8
dice score
8
performance
5
regions
5
comparative analysis
4
analysis u-net
4
u-net u-net3 + for
4

Similar Publications

Diabetic retinopathy (DR) remains a leading cause of preventable blindness worldwide, with the affected population projected to reach 270 million by 2045. Our study analyzed 2 434 interventional trials registered between 2007 and 2024 in the Informa Pharma Intelligence database and found that anti-VEGF agents dominate the therapeutic landscape-bevacizumab represents 24.0 % of studies, ranibizumab 15.

View Article and Find Full Text PDF

Purpose: To evaluate macular vessel density using clinical parameters in patients with type 2 diabetes mellitus (DM) without retinopathy.

Patients And Methods: This cross-sectional study enrolled 32 participants (63 eyes) aged 40-60 years who met the inclusion criteria. Group 1 included 32 eyes of type 2 DM, whereas the rest had no DM.

View Article and Find Full Text PDF

Organoids: their emerging essential role in pathological mechanisms and drug discovery of diabetes and its complications.

Front Pharmacol

August 2025

State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Beijing, China.

Diabetes mellitus is a metabolic disease with a high global prevalence, which affects blood vessels throughout the entire body. As the disease progresses, it often leads to complications, including diabetic retinopathy and nephropathy. Currently, in addition to traditional cellular and animal models, more and more organoid models have been used in the study of diabetes and have broad application prospects in the field of pharmacological research.

View Article and Find Full Text PDF

Background: Artificial intelligence (AI) algorithms offer an effective solution to alleviate the burden of diabetic retinopathy (DR) screening in public health settings. However, there are challenges in translating diagnostic performance and its application when deployed in real-world conditions.

Objective: This study aimed to assess the technical feasibility of integration and diagnostic performance of validated DR screening (DRS) AI algorithms in real-world outpatient public health settings.

View Article and Find Full Text PDF

Dapagliflozin improves diabetic retinopathy in mice by inhibiting LAMA1 and regulating the PI3K/AKT signaling pathway.

Biochem Biophys Res Commun

September 2025

Department of Ophthalmology, Hebei Medical University, NO. 361 Zhongshan East Road, Changan District, Shijiazhuang City, Hebei Province, China; Department of Ophthalmology, Hebei General Hospital, NO. 348 Heping West Road, Xinhua District, Shijiazhuang City, Hebei Province, China. Electronic address

Diabetic retinopathy (DR) is among the most prevalent complications linked to advanced diabetes. Capillary Basement membrane (CBM) thickening is an early clinical manifestation in DR, and Laminin α 1 (LAMA1) is one of the main extracellular matrix components involved in CBM formation. Dapagliflozin (DAPA) has demonstrated efficacy in ameliorating DR.

View Article and Find Full Text PDF